Videos

Pharmaceutical industry and policy stakeholders testified on measures to prevent shortages in generic drugs before the House Energy and Commerce Subcommittee on Health. Witnesses and House m…

Food and Drug Administration Commissioner Scott Gottlieb made keynote remarks at a forum on FDA transparency. He announced a pilot program that aims to make it easier for doctors and patient…

Panelists talked about the challenges and benefits of the Physician Payment Sunshine Act (PPSA). PPSA is a section of the Affordable Care Act that requires drug and medical device companies …

Dr. Janet Woodcock testified at a House Energy and Commerce subcommittee hearing on combating antibiotic resistance and improving drug development. She outlined her concerns in the increasin…

Allan Coukell, deputy director of the Medical Safety Portfolio of the Pew Health Group, talked about the drug safety. Earlier in the week, the House passed the Food and Drug Administration R…

Allan Coukell talked about the Governmental Accountability Office (GAO) report on the make-up of prescription drugs, and he responded to telephone calls and electronic communications. Accord…

Witnesses testified on the safety of pharmaceuticals made fully or partially abroad. A Government Accountability Office (GAO) report indicated that 80 percent of U.S. drug ingredients, and 4…